Skip to Main Content

Paper Details

Identification of the Transcription Factor ATF3 as a Direct and Indirect Regulator of the LDLR.
Metabolites
3
2022
ATF3, ATF3 binding motif, CAD, Coronary artery disease, HMDP, Inflammation, LDL cholesterol, LDLR, MAF BZIP Transcription Factor F, MAFF, Transcription Factor ATF3, activating transcription factor 3, atherosclerosis, cardiovascular, cholesterol, human, human Hep3B liver cells, human liver cells, inflammation, low-density lipoprotein receptor, mouse, mouse models, patients, promoter regions
Author NameAffiliation
Aldons J LusisDavid Geffen School of Medicine, University of California los angeles
Jason C KovacicVictor Chang Cardiac Research Institute
Jason C KovacicSt. Vincent's Clinical School, University of New South Wales
Jason C KovacicIcahn School of Medicine at Mount Sinai, Cardiovascular Research Institute
Heribert SchunkertTechnical University Munich
Heribert Schunkert
  • 1 - 6

Datasets

Release 1.2